Novo Nordisk A/S ADR buy fenjal
Start price
09.05.17
/
50%
€37.03
Target price
18.09.17
€42.00
Performance (%)
10.53%
End price
18.09.17
€40.52
Summary
This prediction ended on 18.09.17 with a price of €40.52. The prediction had a final performance of 10.53%. fenjal has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 9.245% | 9.245% | -38.955% | -58.381% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
According to fenjal what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by fenjal for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
fenjal stimmt dem Sentiment von 'Buy' zu
fenjal stimmt am 09.05.2017 dem Buy-Gesamtsentiment mit dem Kursziel 49.6€ zu.
(Vom Mitglied beendet)
Stopped prediction by fenjal for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€79.00
20.12.24
20.12.24
-
20.12.25
20.12.25
7.85%
10.01.25
10.01.25
Could be worthwhile Investment >10% per year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€154.00
29.05.23
29.05.23
-
29.05.24
29.05.24
10.06%
16.08.23
16.08.23
Could be worthwhile Investment >10% per year


